InvestorsHub Logo
Followers 840
Posts 120470
Boards Moderated 18
Alias Born 09/05/2002

Re: None

Monday, 07/27/2015 9:17:54 AM

Monday, July 27, 2015 9:17:54 AM

Post# of 294
TEVA’s $40.5B acquisition of AGN’s generic-drug business is official, so TEVA is no longer pursuing MYL:

#msg-115711156

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTRS News